Investor's Business Daily on MSN
Vertex Pharma Dips Despite Quarterly Beat And Slight Guidance Book
Vertex stock dipped late Monday despite better-than-expected third-quarter metrics and a slight sales guidance boost.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback